MGMT
Researchers Develop Investigational MDx to ID Glioblastoma Patients who Derive Benefit from Avastin
Premium
This story has been updated with additional information on MDxHealth's MGMT glioblastoma test.
A new study provides further support for MDxHealth's PredictMDx brain cancer test, which predicts which patients will respond to the alkylating chemotherapy temozolomide.